PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.\', \'British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.\', \'Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada; British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.\', \'British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.\', \'British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada.\', \'British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. Electronic address: inna.sekirov@bccdc.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2352-3964(21)00109-210.1016/j.ebiom.2021.103316
?:hasPublicationType
?:journal
  • EBioMedicine
is ?:pmid of
?:pmid
?:pmid
  • 33819740
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.895
?:rankingScore_hIndex
  • 26
is ?:relation_isRelatedTo_publication of
?:title
  • The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all